Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Cash from Operations (2010 - 2026)

Exelixis (EXEL) posted quarterly Cash from Operations of 251845000.0 for Q2 2026, up 19.11% year-over-year from 211437000.0 in Q2 2025, and down 24.49% quarter-over-quarter from 333515000.0 in Q1 2026.

Analysis

Exelixis (EXEL) Cash from Operations (2010 - 2026) Analysis & Trends

Exelixis' Cash from Operations history runs 17 years deep, the most recent figure standing at 251845000.0 for Q2 2026.

  • In Q2 2026, Cash from Operations rose 19.11% year-over-year to 251845000.0; the TTM figure through Apr 2026 stood at 924675000.0 (up 9.74% YoY), while the FY2026 annual figure was 884267000.0, up 26.33% from the prior year.
  • Cash from Operations for Q2 2026 stood at 251845000.0, down from 333515000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 333515000.0 in Q1 2026, with the low at 10571000.0 in Q4 2023.
  • The 5-year median for Cash from Operations is 119548000.0 (2024), against an average of 148942411.76.
  • The sharpest annual moves came in 2023 and 2025: Cash from Operations tumbled 85.66% in 2023, then jumped 2172.85% in 2025.
  • Exelixis' Cash from Operations stood at 73694000.0 in 2022, then sank by 85.66% to 10571000.0 in 2023, then surged by 2466.81% to 271338000.0 in 2024, then climbed by 7.0% to 290322000.0 in 2025, then declined by 13.25% to 251845000.0 in 2026.
  • Business Quant data shows EXEL's Cash from Operations at 251845000.0 in Q2 2026, 333515000.0 in Q1 2026, and 290322000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.13 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 813.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -526.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -387.32 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 462.82 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 326.72 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 728.46 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -88.83 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 307.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 307.74 Mn
Apr 3, 2026 251.85 Mn
Jan 2, 2026 333.52 Mn
Oct 3, 2025 290.32 Mn
Jul 4, 2025 48.99 Mn
Apr 4, 2025 211.44 Mn
Jan 3, 2025 240.26 Mn
Sep 27, 2024 271.34 Mn
Jun 28, 2024 119.55 Mn
Mar 29, 2024 68.82 Mn
Dec 29, 2023 10.57 Mn
Sep 29, 2023 117.37 Mn
Jun 30, 2023 120.98 Mn
Mar 31, 2023 84.41 Mn
Dec 30, 2022 73.69 Mn
Sep 30, 2022 110.07 Mn
Jul 1, 2022 31.13 Mn
Apr 1, 2022 147.72 Mn
Dec 31, 2021 96.45 Mn
Oct 1, 2021 83.31 Mn